Tarlochan S Nijjar

This inventor holds 51 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Humanized Antibodies. Top assignees: Prothena Biosciences Limited, University Health Network, Othair Prothena Limited. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tarlochan S Nijjar. Retrieved from https://idiyas.com/inventor/tarlochan-s-nijjar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 (Patent Applications = 26)

% Patents Active = 70.6

CIPO Patents = 1 (Patent Applications = 24)

EPO Patents = 7 (Patent Applications = 30)

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 242(Granted Patents)

Company Filing History:

34 out of 64

Prothena Biosciences Limited

patents

10 out of 312

University Health Network

patents

9 out of 10

Othair Prothena Limited

patents

4. 3 out of 7

Neotope Biosciences Limited

Neotope Neuroscience Limited

patent

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Humanized Antibodies

Alpha-Synuclein

Tau Detection

Anti-Aβ Antibodies

Transthyretin

Multi-Epitope Vaccine

Alzheimer's Treatment

Sortilin

Medin

IAPP

Anti-Transthyretin

Anti-Abeta

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760096 - ANTIBODIES RECOGNIZING SORTILIN (2026-10-13),

2. 12735507 - ANTIBODIES RECOGNIZING TAU (2026-09-15),

3. 12528858 - Humanized Antibodies That Recognize Alpha-Synuclein (2026-01-20),

4. 12479910 - ANTIBODIES RECOGNIZING TAU (2025-11-25),

5. 12435129 - Anti-Aβ antibodies (2025-10-07),

6. 12247985 - Methods of detecting transthyretin (2025-03-11),

7. 12247056 - Multi-epitope vaccine for the treatment of Alzheimer's disease (2025-03-11),

8. 12049498 - Humanized antibodies recognizing sortilin (2024-07-30),

9. 12049497 - Antibodies recognizing sortilin (2024-07-30),

10. 11965005 - Multi-epitope vaccine for the treatment of Alzheimer's disease (2024-04-23),

11. 11958896 - Antibodies recognizing tau (2024-04-16),

12. 11952406 - Multi-epitope vaccine for the treatment of Alzheimer's disease (2024-04-09),

13. 11945849 - Multi-epitope vaccine for the treatment of Alzheimer's disease (2024-04-02),

14. 11926659 - Antibodies recognizing tau (2024-03-12),

15. 11912759 - Anti-transthyretin antibodies (2024-02-27),

Title: Inventor Tarlochan S Nijjar

Introduction: Tarlochan S Nijjar is a renowned inventor based in Orinda, California.

Latest Patents: Tarlochan S Nijjar holds several patents in the field of renewable energy technologies and sustainable agriculture practices.

Career Highlights: With a background in engineering and a passion for innovation, Nijjar has made significant contributions to the development of eco-friendly solutions for modern challenges.

Collaborations: Throughout his career, Tarlochan S Nijjar has collaborated with various research institutions and universities to further advance his inventions and bring them to market.

Conclusion: Tarlochan S Nijjar's dedication to creating sustainable technologies showcases his commitment to making the world a better place through innovation.

Profile summary based on public USPTO records.